Product image of Ketipinor (Quetiapine) supplied by GNH India

Ketipinor

Active Ingredient:
Quetiapine
Origin:
EU

Ketipinor (Quetiapine)

Quetiapine, the active ingredient in Ketipinor, is a second‑generation atypical antipsychotic presented as an oral dosage form for oral use. It treats schizophrenia, bipolar disorder (both manic and depressive phases) and is used as an adjunct in major depressive disorder in adults.

GNH India supplies Ketipinor as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Orion Corporation

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Quetiapine is indicated for several psychiatric conditions within the schizophrenia and mood‑disorder spectrum.

  • Schizophrenia: reduces psychotic symptoms such as delusions, hallucinations, and thought disorder.
  • Bipolar disorder (manic episodes): stabilises mood and decreases mania severity.
  • Bipolar disorder (depressive episodes): alleviates depressive symptoms.
  • Major depressive disorder (adjunct): enhances antidepressant response when added to standard therapy.

How It Works

  • Quetiapine exerts its antipsychotic and mood‑stabilising actions primarily by antagonising serotonin 5‑HT2A and dopamine D2 receptors, while also blocking histamine H1, adrenergic α1, and various other neurotransmitter receptors. This receptor profile modulates dopaminergic and serotonergic neurotransmission, leading to reduced psychotic activity and improved mood regulation.

Side Effects

Quetiapine may cause a range of adverse reactions, which are generally classified by frequency and severity.

Common Side Effects

  • Sedation or somnolence.
  • Dizziness, especially on standing.
  • Dry mouth.
  • Constipation.
  • Weight gain.
  • Orthostatic hypotension.

Serious or Rare Side Effects

  • Agranulocytosis or severe neutropenia.
  • Neuroleptic malignant syndrome.
  • Tardive dyskinesia or other extrapyramidal symptoms.
  • Emergence of suicidal thoughts or behaviors.

Precautions & Warnings

When prescribing Ketipinor, clinicians should consider several safety measures.

  • Monitor for sedation: advise patients about driving and operating machinery.
  • Assess metabolic parameters: check weight, glucose, and lipid levels regularly.
  • Evaluate for orthostatic hypotension: measure blood pressure on standing.
  • Review psychiatric history: watch for emergence of suicidal ideation.
  • Avoid abrupt discontinuation: taper under medical supervision to reduce withdrawal effects.
  • Store at ambient temperature: keep below 25 °C, in the original container, protected from moisture and light.

Avoid Interactions

Quetiapine can interact with a variety of medicines; some require avoidance while others need close monitoring.

Major Interactions (Avoid)

  • Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): may increase quetiapine plasma levels, raising toxicity risk.
  • Strong CYP3A4 inducers (e.g., rifampin, carbamazepine): may lower efficacy by reducing plasma concentrations.
  • Other CNS depressants (e.g., alcohol, benzodiazepines): may enhance sedation and respiratory depression.

Moderate Interactions (Monitor Closely)

  • Antihypertensives: additive orthostatic hypotension.
  • Anticholinergic agents: may worsen dry mouth and constipation.
  • QT‑prolonging drugs: potential additive cardiac risk.

Frequently Asked Questions

Ketipinor, containing quetiapine, is prescribed for schizophrenia, for the manic and depressive phases of bipolar disorder, and as an adjunctive therapy in major depressive disorder when additional antidepressant effect is needed.

Quetiapine works by blocking several neurotransmitter receptors, most notably serotonin 5‑HT2A and dopamine D2 receptors. This antagonism reduces excessive dopaminergic activity that underlies psychosis and modulates serotonergic pathways that influence mood, providing antipsychotic and mood‑stabilising effects.

The appropriate dose of Ketipinor is determined individually by a qualified prescriber based on the patient’s diagnosis, response, and tolerability. Clinicians adjust the regimen to achieve therapeutic benefit while minimizing adverse effects.

Safety data for quetiapine in pregnancy and lactation are limited. The prescriber must weigh potential benefits against possible risks to the fetus or infant, and use the medication only if clearly needed.

To request Ketipinor, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Ketipinor (quetiapine) and risperidone share a similar atypical antipsychotic class but differ in receptor binding profiles. Quetiapine has stronger antihistamine and α1‑adrenergic blockade, often leading to more sedation and weight gain, whereas risperidone has higher potency at D2 receptors, which may result in a different side‑effect balance.

Ketipinor should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture and direct light, and ensure the container is tightly closed to maintain stability.

Ketipinor is taken orally, usually as a tablet or film‑coated tablet. It should be swallowed whole with water, and may be taken with or without food as directed by the prescriber.

Serious risks include agranulocytosis, neuroleptic malignant syndrome, tardive dyskinesia, and the possible emergence of suicidal thoughts or behaviors. Patients should be monitored closely for signs of infection, severe muscle rigidity, involuntary movements, or worsening mood.

Ketipinor is contraindicated in individuals with known hypersensitivity to quetiapine or any of its excipients, and in patients with a history of severe uncontrolled cardiovascular disease where orthostatic hypotension could be hazardous. Caution is also advised for those with a personal or family history of prolonged QT interval.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Quetiapine

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT